PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Breunig, M.* ; Merkle, J.* ; Wagner, M.* ; Melzer, M.K.* ; Barth, T.F.E.* ; Engleitner, T.* ; Krumm, J.* ; Wiedenmann, S. ; Cohrs, C.M. ; Perkhofer, L.* ; Jain, G.* ; Krüger, J.* ; Hermann, P.C.* ; Schmid, M.* ; Madácsy, T.* ; Varga, A.* ; Griger, J.* ; Azoitei, N.* ; Müller, M.* ; Wessely, O.* ; Robey, P.G.* ; Heller, S.* ; Dantes, Z.* ; Reichert, M.* ; Günes, C.* ; Bolenz, C.* ; Kuhn, F.* ; Maléth, J.* ; Speier, S. ; Liebau, S.* ; Sipos, B.* ; Kuster, B.* ; Seufferlein, T.* ; Rad, R.* ; Meier, M. ; Hohwieler, M.* ; Kleger, A.*

Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells.

Cell Stem Cell 28, 1105-1124.e19 (2021)
Postprint DOI PMC
Open Access Green
Personalized in vitro models for dysplasia and carcinogenesis in the pancreas have been constrained by insufficient differentiation of human pluripotent stem cells (hPSCs) into the exocrine pancreatic lineage. Here, we differentiate hPSCs into pancreatic duct-like organoids (PDLOs) with morphological, transcriptional, proteomic, and functional characteristics of human pancreatic ducts, further maturing upon transplantation into mice. PDLOs are generated from hPSCs inducibly expressing oncogenic GNAS, KRAS, or KRAS with genetic covariance of lost CDKN2A and from induced hPSCs derived from a McCune-Albright patient. Each oncogene causes a specific growth, structural, and molecular phenotype in vitro. While transplanted PDLOs with oncogenic KRAS alone form heterogenous dysplastic lesions or cancer, KRAS with CDKN2A loss develop dedifferentiated pancreatic ductal adenocarcinomas. In contrast, transplanted PDLOs with mutant GNAS lead to intraductal papillary mucinous neoplasia-like structures. Conclusively, PDLOs enable in vitro and in vivo studies of pancreatic plasticity, dysplasia, and cancer formation from a genetically defined background.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
24.633
4.164
15
31
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cdkn2a ; Gnas ; Ipmn ; Kras ; Pdac ; Disease Modelling ; Ductal Pancreatic Organoids ; Human Pluripotent Stem Cells ; In Vitro Differentiation ; Xenograft; Oncogene-induced Senescence; Cellular Senescence; Distinct Tumor; Mouse; Emt; Differentiation; Progenitors; Suppression; Progression; Mutations
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 1934-5909
e-ISSN 1875-9777
Zeitschrift Cell Stem Cell
Quellenangaben Band: 28, Heft: 6, Seiten: 1105-1124.e19 Artikelnummer: , Supplement: ,
Verlag Cell Press
Verlagsort Cambridge, Mass.
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Pioneer Campus (HPC)
Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 30201 - Metabolic Health
90000 - German Center for Diabetes Research
Forschungsfeld(er) Pioneer Campus
Helmholtz Diabetes Center
PSP-Element(e) G-510002-001
G-502600-005
Förderungen Else Kroner-Fresenius-Stiftung
German Cancer Aid
Baden-Wurttemberg-Foundation ExPoChip
INDIMED-Verbund PancChip
Ulm University
European Research Council
EU Horizon 2020
Hungarian Academy of Sciences
Paul Langerhans Institute Dresden (PLID) of Helmholtz Zentrum Munchen at the University Clinic Carl Gustav Carus of Technische Universitat Dresden
German Cancer Aid (Max Eder Program, Deutsche Krebshilfe)
DIR of the NIDCR, a part of the IRP, NIH, DHHS
DFG
Deutsche Forschungsgemeinschaft (DFG)
DOI 10.1016/j.stem.2021.03.005
WOS ID WOS:000658938000014
PubMed ID 33915078
Erfassungsdatum 2021-06-21
[➜Korrektur melden]